Mass vaccination with a two-dose oral cholera vaccine in a refugee camp

Bulletin of the World Health Organization

Volumn 77, Issue 10, 1999, Pages 837-842

  Legros, D ^a   Paquet, C ^a   Perea, W ^b   Marty, I ^b   Kenya Mugisha, N ^c   Royer, H ^a   Neira, M ^d   Ivanoff, B ^d  

^a EPICENTRE   (France)

^b Val de Grâce Military School   (France)

^c MINISTRY OF HEALTH   (Uganda)

^d WORLD HEALTH ORGANIZATION   (Switzerland)

Author keywords

Cholera vaccine; Feasability studies; Immunization programmes; Refugees; Risk factors; Sudan; Uganda

Indexed keywords

CHOLERA VACCINE;

CHOLERA; DISEASE CONTROL; HEALTH CARE; REFUGEE; VACCINATION;

ARTICLE; CHOLERA; FEASIBILITY STUDY; HEALTH CARE COST; HUMAN; REFUGEE; UGANDA; VACCINATION;

AFRICA; AFRICA SOUTH OF THE SAHARA; BACTERIAL AND FUNGAL DISEASES; CHOLERA--PREVENTION AND CONTROL; DELIVERY OF HEALTH CARE; DEMOGRAPHIC FACTORS; DEVELOPING COUNTRIES; DISEASES; EASTERN AFRICA; ENGLISH SPEAKING AFRICA; HEALTH; HEALTH SERVICES; IMMUNIZATION; INFECTIONS; MIGRANTS; MIGRATION; POPULATION; POPULATION DYNAMICS; PRIMARY HEALTH CARE; REFUGEES--WOMEN; RESEARCH REPORT; UGANDA; VACCINATION; VACCINES; WOMEN;

ADMINISTRATION, ORAL; ADOLESCENT; CHILD; CHILD, PRESCHOOL; CHOLERA; CHOLERA VACCINES; DIRECT SERVICE COSTS; FEASIBILITY STUDIES; FEMALE; HUMANS; INFANT; MALE; PATIENT ACCEPTANCE OF HEALTH CARE; PROGRAM EVALUATION; REFUGEES; SUDAN; UGANDA; VACCINATION;

SUDAN;

EID: 0032744953     PISSN: 00429686     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (10)

1. Naficy A et al. Treatment and vaccination strategies for the control of cholera epidemics in Sub-Saharan refugee settings: a cost-effectiveness analysis. Journal of the American Medical Association, 1998, 279 (7): 521-525.
2. Global Task Force on Cholera Control. Guidelines for cholera control. Revised 1992. Geneva, World Health Organization, 1992. (unpublished document WHO/CDD/SER/80.4 rev. 4, available upon request from Child and Adolescent Health and Development, World Health Organization, 1211 Geneva 27, Switzerland).
3. Médecins sans Frontières. Refugee health: an approach to emergency situations. London, Macmillan, 1997.
4. Clemens JD et al. Field trial of oral cholera vaccines in Bangladesh: results from three-year follow-up. Lancet, 1990, 335: 270-273.
5. Van Loon FPL et al. Field trial of inactivated oral cholera vaccines in Bangladesh: results from 5 years of follow-up. Vaccine, 1996, 14 (2): 162-166.
6. Sanchez JL et al. Protective efficacy of oral whole-cell/ recombinant-B-subunit cholera vaccine in Peruvian military recruits. Lancet, 1994, 344: 1273-1276.
7. Mosley WH et al. Report of the 1966-67 cholera vaccine trial in rural East Pakistan. 4. Five years of observation with a practical assessment of the role of a cholera vaccine in cholera control programmes. Bulletin of World Health Organization, 1972, 47: 229-238.
8. Waldman RJ. Cholera vaccination in refugee settings. Journal of the American Medical Association, 1998, 279: 552-553.
9. Conduite à tenir en cas d'épidémie de méningite à méningocoque [What to do when faced with an epidemic of meningococcal meningitis]. Paris, Médecins sans Frontières, 1993.
10. Trach DD et al. Field trial of a locally produced killed oral cholera vaccine in Vietnam. Lancet, 1997, 349: 231-235.